---
title: "Congenital Heart Surgery"
order: 3
category: "Cardiac Surgery"
---

# Congenital Heart Surgery

## Overview

Congenital heart disease (CHD) encompasses a spectrum of structural cardiac abnormalities present at birth, affecting approximately 1% of live births. Advances in surgical techniques, cardiopulmonary bypass, and perioperative care have dramatically improved outcomes, with >90% of patients now surviving to adulthood. This chapter focuses on the surgical management of common congenital cardiac lesions, including septal defects, cyanotic heart disease, and complex malformations requiring staged palliation.

## Classification of Congenital Heart Disease

### Acyanotic Lesions (Left-to-Right Shunts)

**Increased Pulmonary Blood Flow**
- Atrial septal defect (ASD)
- Ventricular septal defect (VSD)
- Patent ductus arteriosus (PDA)
- Atrioventricular septal defect (AVSD)

**Obstructive Lesions**
- Aortic stenosis (AS)
- Pulmonary stenosis (PS)
- Coarctation of the aorta

### Cyanotic Lesions (Right-to-Left Shunts)

**Decreased Pulmonary Blood Flow**
- Tetralogy of Fallot (TOF)
- Tricuspid atresia
- Pulmonary atresia with intact ventricular septum

**Increased Pulmonary Blood Flow**
- Transposition of the great arteries (TGA)
- Total anomalous pulmonary venous return (TAPVR)
- Truncus arteriosus

**Mixed Lesions**
- Single ventricle physiology
- Hypoplastic left heart syndrome (HLHS)

## Atrial Septal Defect (ASD)

### Pathophysiology

**Types**
- **Secundum ASD** (70%): Central defect in fossa ovalis
- **Primum ASD** (15-20%): Lower atrial septum, part of AVSD spectrum, associated with cleft mitral valve
- **Sinus venosus ASD** (10%): Superior (near SVC) or inferior (near IVC), often with anomalous pulmonary venous return
- **Coronary sinus ASD** (<1%): Defect in coronary sinus wall

**Hemodynamics**
- Left-to-right shunt (LA → RA)
- Increased pulmonary blood flow (Qp:Qs ratio >1.5:1 significant)
- RV volume overload → RV dilatation
- Chronic shunting → pulmonary hypertension (Eisenmenger syndrome if severe)

**Natural History**
- Small ASDs (<5 mm): May close spontaneously
- Moderate-large ASDs: Progressive RV dilatation, atrial arrhythmias, pulmonary hypertension
- Symptoms typically in 4th-5th decade if untreated

### Indications for Repair

**Class I**
- Symptomatic ASD (dyspnea, fatigue, arrhythmias)
- Asymptomatic with RV enlargement
- Qp:Qs ≥1.5:1
- Paradoxical embolism

**Contraindication**
- Severe irreversible pulmonary hypertension (PVR >8 Wood units, Eisenmenger syndrome)

### Surgical Technique

**Approach**
- **Median sternotomy** (traditional)
- **Right mini-thoracotomy** (minimally invasive, cosmetic)

**Operative Steps**
1. **Cardiopulmonary bypass**: Bicaval cannulation
2. **Right atriotomy**: Incise right atrium
3. **Identify defect**: Assess size, location, margins
4. **Closure**:
   - **Primary closure**: Direct suture (continuous or interrupted) for small defects (<2 cm)
   - **Patch closure**: Pericardial or Dacron patch for larger defects
   - Ensure no impingement on AV node, coronary sinus
5. **Check for anomalous pulmonary veins** (especially sinus venosus ASD)
6. **Closure of atriotomy**
7. **De-air, wean CPB**

**Transcatheter Closure (Alternative)**
- **Indications**: Secundum ASD with adequate rims, diameter <38-40 mm
- **Devices**: Amplatzer septal occluder, Gore Helex
- **Advantages**: Avoid surgery, faster recovery
- **Limitations**: Not suitable for primum, sinus venosus ASDs; inadequate rims

### Outcomes

- **Mortality**: <1% (surgical or transcatheter)
- **Complications**: Arrhythmias (atrial fibrillation, especially if repaired >40 years old), residual shunt (<5%), device erosion (transcatheter)
- **Long-term**: Excellent quality of life, normalized RV size, reduced arrhythmia risk if repaired early

## Ventricular Septal Defect (VSD)

### Pathophysiology

**Types (by Location)**
- **Perimembranous VSD** (80%): Membranous septum, near tricuspid valve
- **Muscular VSD** (10-20%): Trabecular septum, may be multiple ("Swiss cheese")
- **Inlet VSD** (5-8%): Posterior, near AV valves
- **Outlet (supracristal, doubly committed) VSD** (5%): Below pulmonary and aortic valves, more common in Asian populations

**Hemodynamics**
- Left-to-right shunt (LV → RV)
- Increased pulmonary blood flow
- LV and RV volume overload
- **Small VSD** (restrictive): Low shunt, minimal hemodynamic impact, often close spontaneously
- **Moderate-large VSD** (nonrestrictive): High shunt (Qp:Qs >2:1), pulmonary hypertension, heart failure

**Natural History**
- ~50% of small muscular VSDs close by age 2
- Large VSDs: Heart failure in infancy, pulmonary hypertension, Eisenmenger syndrome if untreated

### Indications for Repair

**Class I**
- Symptomatic VSD (heart failure, failure to thrive)
- Qp:Qs >2:1 with evidence of LV volume overload
- History of endocarditis
- Aortic regurgitation (from prolapsing aortic cusp in outlet VSD)

**Timing**
- **Infants with large VSD**: Repair at 3-6 months if heart failure despite medical management
- **Moderate VSD**: Elective repair at 6-12 months
- **Small VSD**: Observe; may close spontaneously

### Surgical Technique

**Approach**
- **Transatrial**: Through right atrium and tricuspid valve (for perimembranous, inlet VSDs)
- **Transpulmonary**: Through pulmonary artery (for outlet VSDs)
- **Transventricular**: Through RV (for large muscular VSDs, apical VSDs)

**Operative Steps**
1. **CPB**: Aortic and bicaval cannulation
2. **Cardioplegia**: Cardiac arrest
3. **Exposure**: Transatrial approach most common
   - Incise RA, retract tricuspid leaflets
4. **VSD visualization**: Identify defect location, size
5. **Closure**:
   - **Small VSD**: Primary suture closure
   - **Moderate-large VSD**: Patch closure (Dacron, pericardium)
   - Interrupted or continuous sutures
   - **Avoid AV node**: Located at inferior margin of perimembranous VSD (posteroinferior sutures placed superficially or avoided)
6. **Closure of atriotomy**
7. **Wean CPB, assess for residual VSD** (TEE)

**Special Considerations**
- **Multiple muscular VSDs**: Device closure, hybrid approach (surgery + device), or single apical patch excluding multiple defects
- **Outlet VSD with aortic regurgitation**: Repair VSD + aortic valve repair or replacement

### Outcomes

- **Mortality**: <2% (low risk), higher in neonates with complex anatomy
- **Complications**:
  - **Heart block** (1-3%): Damage to AV node/bundle, may require permanent pacemaker
  - **Residual VSD** (5-10%): Usually small, hemodynamically insignificant
  - **Tricuspid regurgitation**: From suture placement
- **Long-term**: Excellent outcomes, normal life expectancy if repaired without residual defects

## Atrioventricular Septal Defect (AVSD, Endocardial Cushion Defect)

### Pathophysiology

**Types**
- **Complete AVSD**: Primum ASD + inlet VSD + common AV valve
- **Partial AVSD**: Primum ASD + cleft mitral valve (no VSD)
- **Transitional**: Intermediate forms

**Associated Conditions**
- **Down syndrome** (40-50% of complete AVSD patients)
- Heterotaxy syndromes

**Hemodynamics**
- Left-to-right shunt at atrial and/or ventricular level
- AV valve regurgitation (common, especially left AV valve)
- Pulmonary hypertension develops early (especially complete AVSD)

### Indications and Timing

**Complete AVSD**
- Repair at **3-6 months of age**
- Earlier if severe heart failure or pulmonary hypertension

**Partial AVSD**
- Elective repair at **2-4 years** (similar to secundum ASD timing, but cleft mitral valve requires earlier intervention if regurgitation significant)

### Surgical Technique

**Operative Steps**
1. **CPB, cardioplegia**
2. **Right atriotomy**
3. **Assess AV valve anatomy**: Single orifice (complete), two orifices (partial)
4. **AV valve repair**:
   - **Cleft closure**: Suture cleft in left AV valve (mitral component)
   - Avoid over-tightening (may cause stenosis)
5. **VSD closure** (complete AVSD):
   - Single-patch or two-patch technique
   - Patch septum, reattach AV valve tissue
6. **ASD closure**: Patch closure
7. **Test valve competence**: Saline test
8. **Wean CPB, TEE assessment**

**Rastelli Classification** (Complete AVSD)
- **Type A**: Superior bridging leaflet chordae to ventricular septum (most common, best surgical outcome)
- **Type B**: Superior bridging leaflet chordae to RV papillary muscle
- **Type C**: Superior bridging leaflet free-floating, chordae to RV papillary muscle (worst outcome)

### Outcomes

- **Mortality**: 2-5% (complete AVSD), <1% (partial AVSD)
- **Complications**:
  - **AV block** (1-5%)
  - **Residual AV valve regurgitation** (10-20%): Reoperation rate 5-10% within 10 years
  - **Residual VSD**
  - **LV outflow tract obstruction** (rare)
- **Long-term**: Good outcomes, particularly for partial AVSD; complete AVSD has higher reoperation risk

## Tetralogy of Fallot (TOF)

### Pathophysiology

**Four Components**
1. **VSD**: Large, nonrestrictive perimembranous or outlet VSD
2. **RV outflow tract obstruction** (RVOTO): Infundibular stenosis, valvular pulmonary stenosis, hypoplastic pulmonary annulus/arteries
3. **Overriding aorta**: Aorta overrides ventricular septum (straddles VSD)
4. **RV hypertrophy**: Secondary to RVOTO

**Hemodynamics**
- **RVOTO** determines degree of cyanosis
- Right-to-left shunt across VSD (desaturated blood bypasses lungs → aorta)
- **Mild RVOTO**: Pink TOF (minimal cyanosis)
- **Severe RVOTO**: Severe cyanosis

**Clinical Presentation**
- **Cyanosis**: Varies by degree of RVOTO
- **Hypercyanotic spells (Tet spells)**: Sudden increase in cyanosis, irritability, hyperpnea
  - Trigger: Crying, feeding, defecation (increases RVOTO, decreases SVR)
  - Management: Knee-chest position, oxygen, morphine, beta-blockers, phenylephrine (increase SVR)
- **Squatting**: Older children squat to increase SVR, reduce right-to-left shunt
- **Clubbing**: Chronic cyanosis

### Indications and Timing

**Primary Repair**
- **Preferred approach**: Complete repair at **3-6 months of age**
- Earlier if severe cyanosis or hypercyanotic spells

**Staged Palliation**
- **Shunt procedure first** (if unfavorable anatomy):
  - Severely hypoplastic pulmonary arteries
  - Multiple aortopulmonary collaterals (MAPCAs)
  - Neonatal presentation with critical RVOTO
- **Blalock-Taussig shunt (BT shunt)**: Subclavian artery to pulmonary artery
  - Provides pulmonary blood flow, allows PA growth
  - Definitive repair later (6-12 months)

### Surgical Technique (Complete Repair)

**Operative Steps**
1. **Median sternotomy, CPB**
2. **Cardioplegia**
3. **VSD closure**:
   - Transatrial or transpulmonary approach
   - Patch closure (Dacron or pericardium)
   - Avoid AV node injury
4. **Relief of RVOTO**:
   - **Infundibular resection**: Excise hypertrophied muscle bundles
   - **Pulmonary valvotomy**: Incise stenotic pulmonary valve
   - **RV outflow patch (transannular patch)**: If annulus hypoplastic (<Z-score -2)
     - Extend incision across pulmonary annulus into main PA
     - Patch with pericardium or Dacron
     - Results in pulmonary regurgitation (PR)
   - **RV-PA conduit**: If pulmonary atresia or absent pulmonary valve
5. **Wean CPB**:
   - Assess RV pressure (should be <0.7× systemic pressure)
   - TEE: Check VSD closure, valve function, PA flow

**Transannular Patch vs. Valve-Sparing Repair**
- **Transannular patch**: Relieves RVOTO but causes chronic PR
  - Long-term PR → RV dilatation, dysfunction, arrhythmias
  - May require pulmonary valve replacement later (adolescence/adulthood)
- **Valve-sparing repair**: Preserve pulmonary valve if annulus adequate
  - Better long-term RV function

### Outcomes

- **Mortality**: <3% (primary repair)
- **Complications**:
  - **Residual RVOTO**: Reoperation if RV pressure >0.7× systemic
  - **Residual VSD**: 5-10%, usually small
  - **Pulmonary regurgitation**: Universal after transannular patch
  - **RV dysfunction**: Chronic PR → RV dilatation, requires pulmonary valve replacement (~15-20% by young adulthood)
  - **Arrhythmias**: Atrial and ventricular arrhythmias (increased with ventriculotomy, chronic RV dilatation)
- **Long-term**: Excellent survival (>90% at 30 years), but require lifelong cardiology follow-up

## Transposition of the Great Arteries (TGA)

### Pathophysiology

**Anatomy**
- **D-TGA (Dextro-TGA)**: Aorta arises from RV, pulmonary artery from LV
- **Parallel circulations**: Deoxygenated blood recirculates (RA → RV → aorta → body), oxygenated blood recirculates (LA → LV → PA → lungs)
- **Incompatible with life** unless mixing occurs (PDA, ASD, VSD)

**Associated Defects**
- **Intact ventricular septum** (60%): Worst prognosis, requires urgent intervention
- **VSD** (40%): Allows mixing, less severe presentation
- **LV outflow tract obstruction**: Pulmonary stenosis (unfavorable for arterial switch)

**Clinical Presentation**
- **Severe cyanosis** at birth (especially if intact septum, closing ductus)
- **Prostaglandin E1 (PGE1)**: Keep ductus open, improve mixing
- **Balloon atrial septostomy (BAS, Rashkind procedure)**: Emergent catheter intervention to create/enlarge ASD, improve mixing

### Surgical Management

**Arterial Switch Operation (ASO, Jatene Procedure)**
- **Preferred operation**, performed in **first week of life** (ideally day 3-7)

**Timing Rationale**
- **LV must maintain systemic pressure**
- After birth, PVR falls → LV pressure falls → LV regresses
- If repair delayed >2-3 weeks, LV unable to support systemic circulation
- **Exception**: TGA with VSD or LV outflow obstruction → LV remains prepared, can operate later

**Operative Technique**
1. **Median sternotomy, CPB**
2. **Cardioplegia**
3. **Transect great arteries**:
   - Divide aorta and pulmonary artery above valves
4. **Coronary artery transfer** (LeCompte maneuver):
   - **Critical step**: Excise coronary arteries from aortic root with buttons of tissue
   - Reimplant into neoaortic root (native pulmonary root)
   - **Coronary anomalies**: Present in ~30%, increase surgical complexity and risk
5. **Neoaortic reconstruction**:
   - Attach native pulmonary root (now neoaorta) to aortic valve
   - Anastomose to distal aorta
6. **Neopulmonary reconstruction**:
   - Attach native aortic root (now neopulmonary) to pulmonary valve
   - Anastomose to pulmonary artery (LeCompte maneuver: bring PA anterior to aorta)
7. **Reconstruct coronary buttons** in neoaorta
8. **Wean CPB**

**Complications of ASO**
- **Coronary ischemia/occlusion**: Kinking, stretching, stenosis at reimplantation site (1-5%)
- **Neoaortic regurgitation**: Pulmonary valve in systemic position (10-20% mild AR at 10 years)
- **Supravalvular stenosis**: Neoaortic or neopulmonary stenosis at suture lines

**Atrial Switch Operations (Historical)**
- **Mustard or Senning procedures**: Baffle atrial septum to redirect blood flow
- **Physiologic repair**: RV remains systemic ventricle
- **Complications**: RV failure, tricuspid regurgitation, baffle obstruction, arrhythmias
- **Obsolete**: Replaced by ASO

### Outcomes

- **ASO mortality**: 2-5%
- **Long-term survival**: >90% at 20 years
- **Complications**: Neoaortic regurgitation (progressive in ~15%), supravalvular stenosis, coronary issues
- **Excellent quality of life**, normal exercise capacity in most patients

## Single Ventricle Physiology and Fontan Procedure

### Pathophysiology

**Conditions with Single Functional Ventricle**
- **Hypoplastic left heart syndrome (HLHS)**: Underdeveloped LV, mitral stenosis/atresia, aortic stenosis/atresia
- **Tricuspid atresia**: No RV inlet
- **Pulmonary atresia with intact ventricular septum (PA/IVS)**: Hypoplastic RV
- **Double inlet left ventricle (DILV)**
- **Unbalanced AVSD**

**Hemodynamics**
- One functional ventricle supports both systemic and pulmonary circulation
- **Mixed circulation**: Oxygenated and deoxygenated blood mix → cyanosis
- **Volume overload**: Single ventricle pumps to both circulations

**Staged Palliation Strategy**
- **Goal**: Separate systemic and pulmonary circulations
- **Fontan circulation**: Passive pulmonary blood flow (systemic venous return → pulmonary arteries directly, bypassing heart)

### Stage 1: Neonatal Palliation (First Days-Weeks of Life)

**Goals**
- Provide adequate pulmonary blood flow
- Ensure unobstructed systemic outflow

**Procedures (Depend on Anatomy)**

**For HLHS:**
- **Norwood Procedure**:
  1. **Neoaortic reconstruction**: Amalgamate hypoplastic ascending aorta, transected main PA, and aortic arch; patch with homograft
  2. **Atrial septectomy**: Unrestrictive mixing
  3. **Pulmonary blood flow source**:
     - **Modified BT shunt** (mBTS): Subclavian artery to PA
     - **RV-PA conduit (Sano shunt)**: RV to PA conduit
- **Hybrid approach** (alternative): Stent ductus, band PAs, balloon atrial septostomy

**For Tricuspid Atresia, PA/IVS:**
- **BT shunt**: If pulmonary blood flow restricted
- **PA band**: If excessive pulmonary blood flow

**Mortality**: 10-20% (highest risk stage)

### Stage 2: Glenn/Hemi-Fontan (4-6 Months)

**Goals**
- Reduce volume load on single ventricle
- Establish partial Fontan circulation

**Procedure**
- **Bidirectional Glenn (BDG)**: Divide SVC, anastomose to right PA (end-to-side)
  - SVC blood flows directly to lungs (passive flow)
  - IVC blood still returns to heart, mixes
  - ~50% of systemic venous return now bypasses heart
- **Hemi-Fontan**: Alternative approach, leave SVC-RA connection, patch separate SVC to PA

**Benefits**
- Reduces ventricular volume overload
- Improves oxygen saturation (~80-85%)
- Allows pulmonary artery growth before Fontan

**Mortality**: 2-5%

### Stage 3: Fontan Completion (2-4 Years)

**Goals**
- Complete separation of systemic and pulmonary circulations
- All systemic venous return to lungs

**Procedure**
- **Total cavopulmonary connection (TCPC)**:
  - **Lateral tunnel**: Intra-atrial baffle directs IVC to PA
  - **Extracardiac conduit** (preferred): IVC to PA conduit (avoids atrial incisions, reduces arrhythmias)
- **Fenestration**: Small opening in Fontan pathway (pop-off valve)
  - Allows right-to-left shunt if pulmonary pressures high
  - Improves early postoperative hemodynamics
  - Closes spontaneously or via catheter later

**Fontan Physiology**
- **Passive pulmonary blood flow**: No ventricle pumps blood to lungs
- Requires:
  - Low pulmonary vascular resistance (PVR <2-3 Wood units)
  - Good ventricular function
  - Competent AV valve
- **Elevated systemic venous pressure**: Chronic venous hypertension

**Mortality**: 1-3%

### Long-Term Fontan Complications

**Arrhythmias**
- Atrial arrhythmias (atrial fibrillation, flutter): 20-40% by adulthood
- Increased with lateral tunnel (atrial suture lines)

**Ventricular Dysfunction**
- Single ventricle chronic volume/pressure overload
- Heart failure, need for transplantation

**Protein-Losing Enteropathy (PLE)**
- Intestinal lymphatic leak secondary to elevated venous pressure
- Diarrhea, hypoalbuminemia, edema, ascites
- Incidence: 3-5%, poor prognosis

**Plastic Bronchitis**
- Bronchial casts, respiratory distress
- Related to lymphatic abnormalities

**Thromboembolism**
- Sluggish flow, atrial arrhythmias
- Anticoagulation often required

**Fontan Failure**
- 10-year failure-free survival: ~85%
- May require heart transplantation

### Outcomes

- **Overall survival**: ~85% at 10 years post-Fontan
- **Quality of life**: Moderate, limited exercise capacity
- **Lifelong follow-up** required

## Coarctation of the Aorta

### Pathophysiology

**Anatomy**
- Narrowing of aortic arch, typically distal to left subclavian artery (juxtaductal)
- **Discrete coarctation**: Short segment stenosis
- **Hypoplastic arch**: Long segment narrowing

**Hemodynamics**
- **LV pressure overload** → LV hypertrophy, hypertension
- **Collateral circulation**: Intercostal arteries, internal mammary arteries bypass obstruction

**Associated Defects**
- Bicuspid aortic valve (50-70%)
- VSD, PDA, mitral valve abnormalities

**Presentation**
- **Neonate**: Severe coarctation → heart failure, shock (when ductus closes)
- **Child/adult**: Hypertension, arm-leg BP gradient, headache, claudication

### Surgical Repair

**Timing**
- **Neonate with critical coarctation**: Emergent repair
- **Older child/adult**: Elective repair

**Techniques**

**Resection with End-to-End Anastomosis**
- **Most common** in neonates/infants
- Excise coarctation segment, sew aorta together
- Risk: Recoarctation (10-20% in neonates)

**Subclavian Flap Aortoplasty**
- Ligate distal left subclavian artery, use as patch to enlarge coarctation
- Risk: Left arm growth discrepancy (rare), loss of subclavian artery

**Patch Aortoplasty**
- Open coarctation, place patch (Dacron, PTFE)
- Risk: Aneurysm formation (10-20%)
- Less commonly used

**Interposition Graft**
- Resect coarctation, place Dacron tube graft
- Used in older patients, calcified coarctation

**Approach**
- **Left posterolateral thoracotomy** (4th intercostal space)
- **No CPB required** (off-pump)

### Transcatheter Intervention

**Balloon Angioplasty**
- For recoarctation or primary coarctation in older children/adults
- Risk: Aneurysm, dissection, recoarctation

**Stent Placement**
- Preferred for adolescents/adults
- Lower recoarctation rate than balloon alone

### Complications

- **Recoarctation**: 10-20% (higher in neonates)
- **Hypertension**: Persistent despite repair in ~30% (repair after age 5 years)
- **Aneurysm formation**: Patch repair, balloon angioplasty
- **Spinal cord ischemia**: Rare (<1%), from intercostal artery interruption

### Outcomes

- **Mortality**: <1% (elective), higher in neonates with complex defects
- **Long-term**: Increased CV risk, require lifelong BP monitoring

## Postoperative Management

### Neonatal/Infant Cardiac Surgery

**Hemodynamic Management**
- **Low cardiac output syndrome (LCOS)**: Common post-CPB in infants
  - Myocardial stunning, residual lesions, pulmonary hypertension
  - Management: Inotropes (dopamine, epinephrine, milrinone), afterload reduction
- **Pulmonary hypertension**: Hyperventilation, sedation, inhaled nitric oxide, sildenafil
- **Arrhythmias**: Junctional ectopic tachycardia (JET) common post-repair
  - Management: Cooling, amiodarone, pacing

**Ventilation**
- Prolonged mechanical ventilation common
- Goal: Wean when hemodynamically stable

**Fluid and Nutrition**
- Fluid restriction (prevent pulmonary edema)
- Early enteral nutrition when stable

**Monitoring**
- **Near-infrared spectroscopy (NIRS)**: Cerebral and somatic oxygenation
- Arterial line, central line, chest tubes

### Single Ventricle Palliation Management

**Post-Glenn/Fontan**
- **Low pulmonary blood flow**: Avoid high PVR (hyperventilation, avoid acidosis, inhaled NO)
- **Maintain preload**: Higher CVP required (Glenn: 12-15 mmHg, Fontan: 15-18 mmHg)
- **Anticoagulation**: Aspirin, sometimes heparin/warfarin (Fontan)
- **Pleural effusions**: Common, may persist weeks (high venous pressure)

## Key Points

1. **Atrial septal defect (ASD)** closure is indicated for symptomatic patients or Qp:Qs ≥1.5:1; secundum ASDs can be closed via transcatheter device, while sinus venosus and primum ASDs require surgery.

2. **Ventricular septal defect (VSD)** repair carries a 1-3% risk of complete heart block due to proximity of the AV node to the inferior rim of perimembranous VSDs; superficial suture placement avoids injury.

3. **Tetralogy of Fallot (TOF)** repair involves VSD closure and RVOT relief; transannular patch relieves obstruction but causes chronic pulmonary regurgitation, often requiring pulmonary valve replacement in adolescence/adulthood.

4. **Arterial switch operation (ASO)** for TGA must be performed in the first week of life (before LV regression); coronary artery transfer is the critical step with 1-5% risk of coronary complications.

5. **Fontan circulation** for single ventricle physiology involves three-stage palliation: Stage 1 (Norwood or BT shunt), Stage 2 (Glenn at 4-6 months), Stage 3 (Fontan at 2-4 years).

6. **Fontan patients** require lifelong follow-up for complications including arrhythmias (20-40%), protein-losing enteropathy (3-5%), and Fontan failure (~15% by 10 years).

7. **Hypoplastic left heart syndrome (HLHS)** Norwood procedure has the highest mortality (10-20%) of staged palliation; hybrid approach offers alternative for high-risk neonates.

8. **Coarctation of the aorta** repaired after age 5 years has 30% persistent hypertension risk; early repair improves long-term cardiovascular outcomes.

9. **Down syndrome** is associated with 40-50% of complete AVSD cases; higher risk of pulmonary vascular disease developing earlier than non-Down syndrome patients.

10. **Low cardiac output syndrome (LCOS)** is common post-CPB in neonates/infants, managed with inotropes (milrinone, epinephrine), afterload reduction, and occasionally mechanical support (ECMO).

## References

1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890-1900.

2. Backer CL, Mavroudis C. Atrial septal defect, partial anomalous pulmonary venous connection, and scimitar syndrome. In: Mavroudis C, Backer CL, eds. Pediatric Cardiac Surgery. 4th ed. Wiley-Blackwell; 2013:283-303.

3. Jacobs ML, Mayer JE Jr. Congenital Heart Surgery Nomenclature and Database Project: ventricular septal defect. Ann Thorac Surg. 2000;69(4 Suppl):S25-35.

4. Apitz C, Webb GD, Redington AN. Tetralogy of Fallot. Lancet. 2009;374(9699):1462-1471.

5. Jatene AD, Fontes VF, Paulista PP, et al. Anatomic correction of transposition of the great vessels. J Thorac Cardiovasc Surg. 1976;72(3):364-370.

6. Norwood WI, Lang P, Hansen DD. Physiologic repair of aortic atresia-hypoplastic left heart syndrome. N Engl J Med. 1983;308(1):23-26.

7. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971;26(3):240-248.

8. d'Udekem Y, Iyengar AJ, Galati JC, et al. Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand. Circulation. 2014;130(11 Suppl 1):S32-38.

9. Goldmuntz E, Bamford R, Karkera JD, et al. CFC1 mutations in patients with transposition of the great arteries and double-outlet right ventricle. Am J Hum Genet. 2002;70(3):776-780.

10. Reller MD, Strickland MJ, Riehle-Colarusso T, et al. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr. 2008;153(6):807-813.
